v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 123,856 $ 200,404
Short-term investments 249,524 300,255
Restricted cash - short-term 194 194
Accounts receivable   1,250
Prepaid expenses and other current assets 18,751 21,170
Total current assets 392,325 523,273
Property and equipment, net 51,029 50,517
Operating lease assets 11,548 12,303
Restricted cash - long-term 1,200 1,200
Other assets 689 827
Total assets 456,791 588,120
Current liabilities:    
Accounts payable 12,301 7,118
Accrued compensation 15,323 20,458
Accrued research and development expenses 12,871 15,813
Deferred revenue 40,968 33,455
Other current liabilities 7,367 6,057
Total current liabilities 88,830 82,901
Deferred revenue - long-term 22,470 27,795
Operating lease liabilities - long-term 12,182 13,041
Other long-term liabilities 1,771 2,044
Total liabilities 125,253 125,781
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of June 30, 2021 and December 31, 2020; 84,754 and 83,372 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 8 8
Additional paid-in capital 1,618,177 1,586,616
Accumulated other comprehensive income 62 296
Accumulated deficit (1,286,709) (1,124,581)
Total stockholders’ equity 331,538 462,339
Total liabilities and stockholders’ equity $ 456,791 $ 588,120

Source